Galmed Pharmaceuticals
GLMD
$0.39
Share price
-1.04%
Change (1 day)
18.15%
Change (1 year)
Categories
Galmed Pharmaceuticals (GLMD) - P/B ratio
P/B ratio as of May 2024 : 0.1725
According to Galmed Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 0.1725.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Galmed Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.1314 | -86.01% |
| 2022-12-31 | 0.9388 | -37.29% |
| 2021-12-31 | 1.50 | -0.28% |
| 2020-12-31 | 1.50 | -14.18% |
| 2019-12-31 | 1.75 | 7.09% |
| 2018-12-31 | 1.63 | -79.45% |
| 2017-12-31 | 7.95 | 106.43% |
| 2016-12-31 | 3.85 | -1.8% |
| 2015-12-31 | 3.92 | 91.27% |
| 2014-12-31 | 2.05 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | -1.52 | -978.50% | 🇺🇸 USA |
 Endo International
ENDPQ | 0.0000 | -100.01% | 🇮🇪 Ireland |
 Catalent CTLT | 2.74 | 1,488.43% | 🇺🇸 USA |